{"Title": ["Why You Need This Medical-Device Company on Your Radar", "Validea Kenneth Fisher Strategy Daily Upgrade Report - 6/3/2020", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 5/17/2020", "Validea's Top Five Healthcare Stocks Based On Joseph Piotroski - 5/17/2020", "Validea Kenneth Fisher Strategy Daily Upgrade Report - 5/15/2020", "Validea Kenneth Fisher Strategy Daily Upgrade Report - 4/29/2020", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 4/19/2020", "Validea's Top Five Healthcare Stocks Based On Joseph Piotroski - 4/19/2020", "Why You Need This Medical-Device Company on Your Radar", "AngioDynamics (ANGO) Q3 2020 Earnings Call Transcript", "Notable Tuesday Option Activity: GOOG, ANGO, FB", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 3/15/2020", "Validea's Top Five Healthcare Stocks Based On Joseph Piotroski - 3/15/2020", "Validea Kenneth Fisher Strategy Daily Upgrade Report - 3/13/2020", "Validea's Top Five Healthcare Stocks Based On Joseph Piotroski - 2/16/2020", "Validea's Top Five Healthcare Stocks Based On Joseph Piotroski - 1/19/2020", "Validea Kenneth Fisher Strategy Daily Upgrade Report - 4/14/2020", "Health Care Sector Update for 01/07/2020: APLS, XERS, ANGO, JNJ, PFE, ABT, MRK, AMGN", "Validea's Top Five Healthcare Stocks Based On Joseph Piotroski - 12/15/2019", "AngioDynamics (ANGO) Q1 2020 Earnings Call Transcript", "Why GoPro, AngioDynamics, and Resources Connection Slumped Today", "Health Care Sector Update for 10/03/2019: APDN, PBYI, ANGO, JNJ, PFE, ABT, MRK, AMGN", "Monday's ETF Movers: IHI, GDXJ", "Relative Strength Alert For AngioDynamics", "AngioDynamics (ANGO) Q2 2020 Earnings Call Transcript", "AngioDynamics (ANGO) Q3 2019 Earnings Conference Call Transcript", "Health Care Sector Update for 04/02/2019: ADMA, EVOK, ANGO, JNJ, PFE, ABT, MRK, AMGN", "AngioDynamics (ANGO) Q3 2019 Earnings Conference Call Transcript", "Earnings Reaction History: ANGIODYNAMICS, 57.1% Follow-Through Indicator, 7.3% Sensitive", "Pre-Market Earnings Report for April 2, 2019 : WBA, LW, ANGO, MTNB", "Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for", "Avanos (AVNS) Q4 Earnings Beat, Revenues Miss, Shares Down", "AngioDynamics (ANGO) Q4 2019 Earnings Call Transcript", "Cooper Companies' (COO) Q1 Earnings Beat, Revenues Rise Y/Y", "GNC Holdings' (GNC) Q4 Earnings Miss Estimates, Margins Fall", "Here's Why You Should Invest in AngioDynamics Stock Now", "HMS Holdings' (HMSY) Q4 Earnings Beat, Revenues Rise Y/Y", "PRA Health's (PRAH) Q4 Earnings Top, Revenues Lag Estimates", "Inogen (INGN) Q4 Earnings Beat Estimates, Rental Revenues Up", "OPKO Health (OPK) Reports Loss in Q4, Misses on Revenues", "AMN Healthcare (AMN) Q4 Earnings Top, Revenues Lag Estimates", "Bio-Rad (BIO) Earnings and Revenues Beat Estimates in Q4", "New Strong Buy Stocks for February 28th", "Amedisys (AMED) Tops Earnings and Revenue Estimates in Q4", "Orthofix (OFIX) Earnings Beat Estimates in Q4, Margins Fall", "Patterson Companies (PDCO) Earnings Match Estimates in Q3", "Commit To Buy AngioDynamics At $20, Earn 9% Annualized Using Options", "Tandem (TNDM) Posts Earnings in Q4, Revenues Top Estimates", "Penumbra (PEN) Earnings and Revenues Beat Estimates in Q4", "Fresenius Medical (FMS) Earnings Beat, Revenues Miss in Q4", "Masimo (MASI) Q4 Earnings and Revenues Beat, Guidance Solid", "Teleflex (TFX) Q4 Earnings Miss Estimates, Margins Rise", "Integra's (IART) Q4 Earnings and Revenues Beat Estimates", "DexCom's (DXCM) Q4 Earnings Beat, International Revenues Up", "Chemed (CHE) Q4 Earnings Beat Estimates, Gross Margin Falls", "Allscripts (MDRX) Q4 Earnings Lag Estimates, Bookings Up Y/Y", "Insulet (PODD) Beats Earnings and Revenue Estimates in Q4", "NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall", "Genomic Health (GHDX) Q4 Earnings Beat Estimates, Margins Up", "CVS Health's (CVS) Q4 Earnings Top Estimates, Margins Up", "Henry Schein's (HSIC) Q4 Earnings Top, Revenues Lag Estimates", "Medtronic (MDT) Beats on Q3 Earnings, Gross Margin Down", "Ecolab (ECL) Earnings and Revenues Match Estimates in Q4", "Cryolife (CRY) Earnings Miss, Revenues Top Estimates in Q4", "Integer Holdings' (ITGR) Q4 Earnings Beat, '19 View Strong", "NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall", "Quest Diagnostics (DGX) Q4 Earnings in Line, Margins Down", "Medidata (MDSO) Q4 Earnings Beat, Revenues Miss Estimates", "Bruker (BRKR) Q4 Earnings In Line, Margin Growth Strong", "STERIS (STE) Q3 Earnings In Line, Revenues Beat Estimates", "IRADIMED (IRMD) Q4 Earnings Surpass Estimates, Margins Up", "Quidel (QDEL) Q4 Earnings and Revenues Surpass Estimates", "Phirbo (PAHC) Q2 Earnings Lag Estimates, Operating Margin Up", "LabCorp's (LH) Q4 Earnings and Revenues Surpass Estimates", "Cardinal Health (CAH) Beats on Q2 Earnings, Ups FY19 View", "Myriad Genetics (MYGN) Q2 Earnings & Revenues Miss Estimates", "Cerner (CERN) Q4 Earnings Meet Estimates, Revenues Miss", "Luminex (LMNX) Q4 Earnings Miss, 2019 Guidance Lacks Luster", "Haemonetics (HAE) Earnings Top, Revenues Lag Estimates in Q3", "Omnicell (OMCL) Q4 Earnings Beat Estimates, Revenues Miss", "QIAGEN's (QGEN) Q4 Earnings In Line, Revenues Miss Mark", "Becton, Dickinson (BDX) Q1 Earnings In Line With Estimates", "Omnicell Solid on Geographic Expansion Amid Stiff Competition", "AngioDynamics (ANGO) Up 8.7% Since Last Earnings Report: Can It Continue?", "PerkinElmer (PKI) Q4 Earnings Beat, Diagnostics Grows Y/Y", "McKesson (MCK) Beats on Q3 Earnings, Gains From Solid View", "Cardiovascular Systems (CSII) Q2 Earnings Top, Revenues Meet", "Boston Scientific (BSX) Beats on Q4 Earnings, Margins Dip", "Edwards Lifesciences (EW) Q4 Earnings In Line, Revenues Top", "ABIOMED (ABMD) Q3 Earnings Beat, Impella Maintains Momentum", "IDEXX (IDXX) Q4 Earnings Top Estimates, Raises '19 EPS View", "Hologic's (HOLX) Q1 Earnings Beat Estimates, Guidance Raised", "Surmodics (SRDX) Q1 Earnings & Revenues Beat, Guidance Solid", "AmerisourceBergen (ABC) Beats on Q1 Earnings, Trims EPS View", "Baxter's (BAX) Earnings, Revenues Beat Estimates in Q4", "Zimmer Biomet (ZBH) Q4 Earnings Meet Estimates, Revenues Top", "Align Technology (ALGN) Beats on Earnings and Revenues in Q4", "Varian Strong on Global Expansion and Proton Therapy Arm", "Stryker (SYK) Q4 Earnings Beat, International Revenues Surge", "Hill-Rom's (HRC) Earnings and Revenues Top Estimates in Q1", "Intuitive Surgical (ISRG) Earnings Miss, Revenues Beat in Q4", "Accuray's (ARAY) Q2 Loss Narrows, Radixact Demand Shoots Up", "CONMED (CNMD) Q4 Earnings Match Estimates, Revenues Beat", "Thermo Fisher (TMO) Beats on Earnings and Revenues in Q4", "Align Technology (ALGN) Beats on Earnings and Revenues in Q4", "Varian Strong on Global Expansion and Proton Therapy Arm", "AngioDynamics (ANGO) Beats Q2 Earnings and Revenue Estimates", "Pre-Market Earnings Report for January 4, 2019 : LW, RPM, ANGO", "AngioDynamics (ANGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release", "Here's Why Investors Should Hold AngioDynamics Stock Now", "AngioDynamics (ANGO) Down 6.9% Since Last Earnings Report: Can It Rebound?", "Here's Why Investors Should Hold AngioDynamics (ANGO) Now", "AngioDynamics (ANGO) Q2 Earnings Beat on Gains From NanoKnife", "Earnings Reaction History: AngioDynamics Inc., 50.0% Follow-Through Indicator, 6.5% Sensitive", "AngioDynamics (ANGO) Q1 Earnings Preview: What to Watch Ahead of the Release", "What's in Store for AngioDynamics (ANGO) in Q1 Earnings?", "Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now", "AngioDynamics (ANGO) to Acquire RadiaDyne, Boost Oncology", "New Strong Sell Stocks for September 7th", "AngioDynamics (ANGO) Q1 Earnings Miss, '19 Sales View Up", "AngioDynamics' (ANGO) BioSentry Buyout to Boost Oncology", "Why Is AngioDynamics (ANGO) Up 5.02% Since Its Last Earnings Report?", "Align, AngioDynamics and Caterpillar highlighted as Zacks Bull and Bear of the Day", "Bear of the Day: AngioDynamics (ANGO)", "AngioDynamics (ANGO) Q4 Performance Dull, Competition Rife", "AngioDynamics (ANGO) Misses Q4 Earnings & Revenue Estimates", "Mid-Morning Market Update: Markets Open Lower; Fastenal Profit Tops Views", "New Strong Sell Stocks for August 21st", "Pre-Market Earnings Report for July 11, 2018 : FAST, MSM, ANGO", "Stocks Rally Ahead of Tariff Day", "What's in Store for AngioDynamics (ANGO) in Q4 Earnings?", "Why Is AngioDynamics (ANGO) Up 13.9% Since Its Last Earnings Report?", "AngioDynamics (ANGO) Product Line Strong, Debt Level High", "AngioDynamics (ANGO) Beats on Q3 Earnings, Reiterates View", "AngioDynamics (ANGO) Q3 2018 Earnings Conference Call Transcript", "Mid-Morning Market Update: Markets Open Lower; Fastenal Profit Tops Views", "Pre-Market Earnings Report for July 11, 2018 : FAST, MSM, ANGO", "Stocks Rally Ahead of Tariff Day", "AngioDynamics (ANGO) Banks on Buyouts, Debt Level High", "Zacks.com featured highlights include: AngioDynamics, Zumiez, GP Strategies, AngloGold and Raymond James", "Bet on These 5 PEG-Ratio Based GARP Picks", "AngioDynamics (ANGO) Misses on Earnings, Revenues in Q2", "Earnings Reaction History: AngioDynamics Inc., 60.0% Follow-Through Indicator, 6.1% Sensitive", "Health Care Sector Update for 01/04/2018: ANGO,APOP.AST,ONTX", "Pre-Market Earnings Report for January 4, 2018 : WBA, MON, LW, RPM, ANGO", "Can AngioDynamics (ANGO) Pull a Surprise in Q2 Earnings?", "Why Is AngioDynamics (ANGO) Up 5.3% Since the Last Earnings Report?", "AngioDynamicis' (ANGO) Solero MTA System to Drive Growth", "AngioDynamics (ANGO) Misses on Earnings & Revenues in Q1", "Health Care Sector Update for 09/28/2017: ANGO,ZYNE,DXCM", "Earnings Reaction History: AngioDynamics Inc., 60.0% Follow-Through Indicator, 6.3% Sensitive", "Can AngioDynamics (ANGO) Spring a Surprise in Q1 Earnings?", "AngioDynamics' BioFlo Platform Strong, Debt Levels High", "AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue?", "AngioDynamics Inc (ANGO) Files 10-K for the Fiscal Year Ended on May 31, 2017", "Monday 7/24 Insider Buying Report: TTS, ANGO", "AngioDynamics (ANGO) Shares Down Despite Q4 Earnings Beat", "Earnings Reaction History: AngioDynamics Inc., 60.0% Follow-Through Indicator, 5.4% Sensitive", "Pre-Market Earnings Report for September 28, 2017 : ACN, CAG, MKC, MTN, CMD, RAD, ANGO, FGP, OMN, HHS", "AngioDynamics (ANGO) Down 11.7% Since Earnings Report: Can It Rebound?", "AngioDynamics (ANGO) Prices 2.5M Secondary Share Offering", "5 Cheap Value Stocks to Tame a Capricious Market in Q2", "AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View", "Here's Why You Should Steer Clear of Mednax (MD) for Now", "Pre-Market Earnings Report for March 30, 2017 : SAIC, LNN, NDRM, ANGO, TITN, CAAS, AFMD, SNAK, ALDX, CDTI, LIQT, ROSG", "AngioDynamics Microwave Tissue Ablation System Now CE Marked", "Waiting for Wednesday", "Zacks.com featured highlights: First American Financial, AngioDynamics, Microsemi, Thermo Fisher Scientific and F5 Networks", "5 GARP Stocks to Benefit from Trump Induced Rebound", "AngioDynamics (ANGO) Announces 2.5M Secondary Offering", "The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, Arch Capital Group, IPG Photonics, AngioDynamics and Express Scripts Holding", "5 GARP Stocks to Buy Now", "Accuray (ARAY) Incurs Wider Loss in Q1, Misses on Revenue", "AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View", "Luminex (LMNX) Misses Q3 Earnings Estimates, '16 View Up", "Healthways (HWAY) Misses Q3 Earnings, Revenue Estimates", "Integer (ITGR) Beats Earnings and Revenue Estimates in Q3", "Cerner (CERN) Misses Q3 Earnings & Revenue Estimates", "Fresenius Medical (FMS) Q3 Earnings, Sales Beat Estimates", "Accuray (ARAY) Q1 Loss Wider than Expected, Revenues Lag", "Ecolab's (ECL) Q3 Earnings Beat, Revenues Miss Estimates", "Becton, Dickinson (BDX) Beats on Q4 Earnings & Revenues", "CONMED (CNMD) Q3 Earnings Meet Estimates, Improve Y/Y", "Cardinal Health (CAH) Q1 Earnings Beat Estimates, Fall Y/Y", "Quality Systems (QSII) Beats Earnings and Revenues in Q2", "Stryker (SYK) Down despite Q3 Earnings and Revenue Beat", "Varian Medical (VAR) Beats on Q4 Earnings and Revenues", "Universal Health (UHS) Misses Q3 Earnings, Narrows View", "Your Personal Healthcare Investment Plan", "Abiomed (ABMD) Q2 Earnings Lag Estimates, Revenues Beat", "Zacks.com featured highlights: AngioDynamics, Luxoft Holding, Boston Scientific, Popeyes Louisiana Kitchen and Thermo Fisher Scientific", "Baxter International (BAX) Q3 Earnings, Sales Top; View Up", "5 GARP Stocks Well Positioned to Provide Impressive Yields", "Zacks.com featured highlights: GATX, Chemours, AngioDynamics, Koppers Holdings and Standard Motor Products", "athenahealth (ATHN): Beats on Q3 Earnings, Inks Partnership", "Buy These 5 Stocks for Their Solid Relative Price Strength", "Top 10 Stocks Under $20", "C.R. Bard (BCR) Beats Q3 Earnings & Sales, FY16 View Up", "Zacks.com featured highlights: AngioDynamics, Luxoft Holding, Boston Scientific, Popeyes Louisiana Kitchen and Thermo Fisher Scientific", "Baxter International (BAX) Q3 Earnings, Sales Top; View Up", "5 GARP Stocks Well Positioned to Provide Impressive Yields", "Zacks.com featured highlights: GATX, Chemours, AngioDynamics, Koppers Holdings and Standard Motor Products", "athenahealth (ATHN): Beats on Q3 Earnings, Inks Partnership", "Buy These 5 Stocks for Their Solid Relative Price Strength", "Top 10 Stocks Under $20", "C.R. Bard (BCR) Beats Q3 Earnings & Sales, FY16 View Up", "AngioDynamics Hits New 52-Week High on Solid Q4 Results", "Zacks.com featured highlights: Tenneco, WNS, AngioDynamics, Teleflex and j2 Global", "5 GARP Stocks Poised to Deliver Good Returns", "AngioDynamics (ANGO) Hits 52-Week High on Positive View", "AngioDynamics (ANGO) Tops Q4 Earnings, '17 View Positive", "Pre-Market Earnings Report for July 13, 2016 : CBSH, ANGO", "Can AngioDynamics' (ANGO) Q4 Earnings Pull a Surprise?", "Pre-Market Earnings Report for October 5, 2016 : MON, STZ, GPN, AYI, RPM, AZZ, ANGO", "Thermo Fisher-Siemens Collaborate to Aid Molecular Testing", "Earnings Reaction History: AngioDynamics Inc., 50.0% Follow-Through Indicator, 4.6% Sensitive", "After-Hours Earnings Report for April 7, 2016 : PSMT, WDFC, RECN, ANGO, SEAC", "Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision", "Mazor Robotics Receives 5 Orders in Q1, Shares Down", "Can the Uptrend Continue for AngioDynamics (ANGO)?", "Inogen (INGN) Q4 Earnings: A Surprise in the Cards?", "AngioDynamics Tops Q3 Earnings, Sales; FY16 View Pruned", "AngioDynamics: Health Canada Okays Celerity with Navigation", "AngioDynamics Q2 Earnings In Line, Sales Top; '16 View Cut", "Earnings Reaction History: AngioDynamics Inc., 50.0% Follow-Through Indicator, 4.5% Sensitive", "After-Hours Earnings Report for January 7, 2016 : BBBY, SNX, HELE, PSMT, WDFC, CUDA, ANGO, TCS, FC", "AngioDynamics: FDA Calls Off Warnings Against Facilities", "AngioDynamics Addresses FDA Warning for NanoKnife System", "AngioDynamics Expands in Asia with NanoKnife Approvals", "Add AngioDynamics (ANGO) to Your Portfolio: Here's Why", "AngioDynamics Down on In-Line Q1 Earnings, Sales Miss", "After-Hours Earnings Report for October 8, 2015 : HELE, ANGO, ATNY, AA", "Can AngioDynamics' (ANGO) Q1 Earnings Pull a Surprise?", "AngioDynamics Q4 Earnings Meet, Sales Hit by Forex Woes - Analyst Blog", "Will AngioDynamics (ANGO) Miss Q4 Earnings Estimates? - Analyst Blog", "Company News for April 13, 2015 - Corporate Summary", "AngioDynamics Lags Earnings on Lower Sales, View Tepid - Analyst Blog", "AngioDynamics (ANGO) in Focus: Stock Falls 6.7%", "After-Hours Earnings Report for April 9, 2015 : PSMT, ANGO, RT", "Can AngioDynamics (ANGO) Surprise Earnings in Q3? - Analyst Blog", "AngioDynamics Celerity System Gets Expanded FDA Approval - Analyst Blog", "AngioDynamics Beats Q2 Earnings by a Penny, Guides Up - Analyst Blog", "Earnings Reaction History: AngioDynamics Inc., 50.0% Follow-Through Indicator, 4.1% Sensitive", "After-Hours Earnings Report for January 8, 2015 : BBBY, PSMT, CUDA, HELE, TCS, ANGO, RT, FC, EOPN, VOXX", "Natus Medical Advances Newborn Care with Nicview Buyout - Analyst Blog", "Earnings Reaction History: AngioDynamics Inc., 50.0% Follow-Through Indicator, 4.2% Sensitive", "After-Hours Earnings Report for April 9, 2015 : PSMT, ANGO, RT", "Can AngioDynamics (ANGO) Surprise Earnings in Q3? - Analyst Blog", "AngioDynamics Celerity System Gets Expanded FDA Approval - Analyst Blog", "AngioDynamics Beats Q2 Earnings by a Penny, Guides Up - Analyst Blog", "Adverse Reimbursement Verdict for Cyberonics' VNS Therapy - Analyst Blog", "Merit Medical Hits 52-Week High on Product Pipeline Strength - Analyst Blog", "AngioDynamics (ANGO) Hits 52-Week High on Positive View - Analyst Blog", "IDEXX CAG, Global Growth Solid; Catalyst One in Focus in '15 - Analyst Blog", "Merit Medical Wins FDA Approval for Multiple Devices - Analyst Blog", "AngioDynamics (ANGO) Signs PICC Deal with HealthTrust - Analyst Blog", "Hologic (HOLX) Turns Around: Should You Invest Now? - Analyst Blog", "Thoratec Completes Enrollment for HeartMate III CE Mark Trial - Analyst Blog", "Varian Medical (VAR) to Display New Technologies at RSNA - Analyst Blog", "Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog", "Commit To Buy AngioDynamics At $15, Earn 9.6% Annualized Using Options", "CR Bard Strong on Acquisitions, FDA Nod for Lutonix DCB - Analyst Blog", "Fresenius Medical (FMS) Scales 52-Week High on Strong Q3 - Analyst Blog", "Edwards Lifesciences Strong on Robust Q3, Raised Outlook - Analyst Blog", "Oxford Immunotec (OXFD) Looks Good: Stock Rises 5.6% - Tale of the Tape", "AngioDynamics (ANGO) Stock: Moving Average Crossover Alert - Tale of the Tape", "Sirona Dental Lags Q4 Earnings by a Penny, Tops Revenues - Analyst Blog", "Cepheid Gets FDA Clearance for Xpert Flu/RSV XC Test - Analyst Blog", "Cyberonics Slumps: CYBX Falls 5.1% in Session - Tale of the Tape", "Luminex Grows on Product Launches & Strategic Partnerships - Analyst Blog", "Cyberonics (CYBX) in Focus: Stock Adds 13.4% in Session - Tale of the Tape", "AngioDynamics (ANGO) Reiterates FY15, Long-Term Outlook - Analyst Blog", "Navidea Biopharmaceuticals (NAVB) Jumps: Stock Up 7.8% - Tale of the Tape", "Fluidigm (FLDM) Now a Strong Buy on Key Product Releases - Analyst Blog", "Teleflex (TFX) Hits 52-Week High on Strong Q3 Results - Analyst Blog", "Varian Medical (VAR) Down to Strong Sell on Dismal Q3 - Analyst Blog", "Abiomed (ABMD) Hits 52-Week High on Strong Q2 Results - Analyst Blog", "Cyberonics Beats Q2 Earnings, Sales Up, EPS View Retained - Analyst Blog", "Roka Bioscience (ROKA) in Focus: Stock Surges 19.3% - Tale of the Tape", "Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog", "Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape", "Thoratec Q3 Earnings & Revenues Lag Estimates, Down Y/Y - Analyst Blog", "Foundation Medicine Slumps: FMI Tumbles 9.6% in Session - Tale of the Tape", "Hologic Beats Q4 Earnings, Sales as All Segments Gain - Analyst Blog", "Teleflex Beats on Q3 Earnings & Revenues, Outlook Raised - Analyst Blog", "Thoratec (THOR) Down to Strong Sell on Growing Headwinds - Analyst Blog", "CryoLife Q3 Earnings Fall, Revenues Rise Y/Y; Shares Tank - Analyst Blog", "Becton, Dickinson (BDX) Beats Q4 Earnings, Revenues - Analyst Blog", "Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog", "Techne Corp. (TECH) Q1 Earnings, Revenues Miss Estimates - Analyst Blog", "Abiomed Tops Q2 Earnings, Revenues; FY15 Sales View Up - Analyst Blog", "Accuray (ARAY) Q1 Loss Wider Than Expected, Revenues Lag - Analyst Blog", "Greatbatch Beats Q3 Earnings Estimates; Upgrades '14 View - Analyst Blog", "Symmetry Medical Q3 Earnings & Revenues Miss, Rise Y/Y - Analyst Blog", "CryoLife Q3 Earnings Fall, Revenues Rise Y/Y; Shares Tank - Analyst Blog", "Becton, Dickinson (BDX) Beats Q4 Earnings, Revenues - Analyst Blog", "Edwards Lifesciences Tops Q3 Earnings, Revenues; Ups View - Analyst Blog", "RTI Surgical (RTIX) Jumps: Stock Moves 12.6% Higher - Tale of the Tape", "Quality Systems Misses on Q2 Fiscal Earnings by a Penny - Analyst Blog", "Intuitive Surgical Q3 Earnings Fall but Beat Estimates - Analyst Blog", "After Hours Most Active for Oct 20, 2014 : AAPL, INTC, QQQ, BSBR, HAL, ANGO, JPM, NCT, KEY, ABBV, FOXA, MRVL", "Luminex (LMNX) Upgraded to Strong Buy on Impressive Q3 - Analyst Blog", "IDEXX Tops Q3 Earnings and Revenues; Guidance Revised - Analyst Blog", "Luminex (LMNX) Crumbles: Stock Falls by 7.5% - Tale of the Tape", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "AngioDynamics (ANGO) Jumps: Stock Moves 5.6% Higher - Tale of the Tape", "Company News for October 13, 2014 - Corporate Summary", "AngioDynamics Q1 Earnings & Revenues Beat, '15 View Up - Analyst Blog", "After-Hours Earnings Report for October 9, 2014 : FDO, INFY, HELE, CMTL, ANGO, ENZ, VOXX, JOEZ", "Cepheid Q3 Loss Narrower than Expected, Sales View Upped - Analyst Blog", "Updated Research Report on AngioDynamics - Analyst Blog", "Weakness Seen in AngioDynamics (ANGO): Stock Tumbles 7.8% - Tale of the Tape", "Sector Update: Healthcare", "Healthcare Stocks Resume Slide; AngioDynamics Inching Lower After Q3 Earnings Miss", "Earnings Reaction History: AngioDynamics Inc., 50.0% Follow-Through Indicator, 4.1% Sensitive", "After-Hours Earnings Report for April 9, 2014 : BBBY, APOG, NOG, ANGO, RT, SIGM, ATNY, RELL, SLP, JOEZ", "AngioDynamics Q4 Earnings Beat, Revenues Up on Higher Sales - Analyst Blog", "AngioDynamics (ANGO) in Focus: Stock Moves 5.7% Higher - Tale of the Tape", "Commit To Buy AngioDynamics At $12.50, Earn 8.6% Annualized Using Options", "AngioDynamics Gets 3rd FDA Approval for BioFlo - Analyst Blog", "Coverage on Covance Initiated - Analyst Blog", "Cyberonics Upped to Buy - Analyst Blog", "BioScrip Down on Q4 Loss, Poor Outlook - Analyst Blog", "FDA Expands Angiovac Clearance for AngioDynamics - Analyst Blog", "Wider Q4 Loss, Poor Outlook at Volcano Corp. - Analyst Blog", "Balanced View on Omnicell - Analyst Blog", "Balanced View on PetMed - Analyst Blog", "Updated Research Report on Cepheid - Analyst Blog", "Pacific Biosciences (PACB) Jumps: Stock Moves 8.3% Higher - Tale of the Tape", "Masimo Q4 Earnings Meet Ests - Analyst Blog", "Sirona Dental Earnings Beat by a Penny, Shares Up - Analyst Blog", "Fresenius Medical Care Beats on Q4 Earnings - Analyst Blog", "Wider Q4 Loss, Poor Outlook at Volcano Corp. - Analyst Blog", "Q1 Earnings Beat & Revs in Line at Hologic - Analyst Blog", "Accuray Sees Narrower Loss, Hits 52-Week High - Analyst Blog", "Accuray (ARAY) Catches Eye: Stock Jumps 15.3% - Tale of the Tape", "Cepheid Reports Q4 Loss, Beats on Revs - Analyst Blog", "Abiomed Earnings Rise, Tops Estimates - Analyst Blog", "Omnicell Misses on Q4 Earnings, Beats Revs - Analyst Blog", "Thoratec Earnings Meet Ests but Fall Y/Y - Analyst Blog", "Luminex Earnings Beat but Fall Y/Y, Shares Down - Analyst Blog", "Q1 Earnings Beat & Revs in Line at Hologic - Analyst Blog", "Intuitive Surgical Expects Lower Revenues - Analyst Blog", "Novadaq Technologies (NVDQ) in Focus: Stock Moves 3.1% Higher - Tale of the Tape", "Medtronic Still at Neutral - Analyst Blog", "Mindray Revises Revenue Guidance - Analyst Blog", "Intuitive Surgical Tops on Q4 Earnings & Revs - Analyst Blog", "Quality Systems (QSII) Catches Eye: Stock Jumps 8.4% - Tale of the Tape", "Boston Scientific Kept at Neutral - Analyst Blog", "AngioDynamics Remains Neutral - Analyst Blog", "AngioDynamics Inc. (ANGO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report", "Align Pinned at Outperform - Analyst Blog", "AngioDynamics Misses on Fiscal Q2 Earnings - Analyst Blog", "After-Hours Earnings Report for January 9, 2014 : AA, INFY, PSMT, SNX, HELE, PRGS, EOPN, ANGO", "Illumina Rises on Prelim Q4 Results - Analyst Blog", "Volcano Sells on Prelim 2014 Outlook - Analyst Blog", "Boston Scientific Kept at Neutral - Analyst Blog", "AngioDynamics Remains Neutral - Analyst Blog", "DexCom Hits New 52-Week High - Analyst Blog", "Luminex Remains Neutral - Analyst Blog", "BSX' Promus PREMIER DES Gets FDA Nod - Analyst Blog", "Accuray on Growth Track - Analyst Blog", "Masimo Reaches New 52-Week High - Analyst Blog", "ECTE Shares Surge on Positive Study Results - Analyst Blog", "Cyberonics Beats on Q2 Earnings, Guides Up - Analyst Blog", "Sirona Dental Earnings Miss Fiscal Q4 Ests - Analyst Blog", "PetMed Slips to Neutral - Analyst Blog", "Strength Seen in IMRIS (IMRS): Stock Surges 17.7% - Tale of the Tape", "Teleflex Unveils New Product Line - Analyst Blog", "Teleflex Unveils New Product Line - Analyst Blog", "TMO-LIFE Deal Gains Regulatory Nod - Analyst Blog", "ECTE Shares Surge on Positive Study Results - Analyst Blog", "Varian Sees Flat Earnings, Lags Estimates - Analyst Blog", "ISRG Q3 Earnings Beat But Down Y-o-Y - Analyst Blog", "AngioDynamics Bags Major Deal - Analyst Blog", "ANGO Beats Q1 Earnings, Hits 52-Week High - Analyst Blog", "After-Hours Earnings Report for October 10, 2013 : MU, SWY, OZRK, LRN, EOPN, ANGO", "Syneron Medical (ELOS) in Focus: Stock Surges 16.4% - Tale of the Tape", "ANGO Launches BioFlo PICC Trial - Analyst Blog", "AngioDynamics Stays Neutral - Analyst Blog", "AngioDynamics Restructures Debt - Analyst Blog", "Health Canada Approves ANGO's Celerity System - Analyst Blog", "New Study for ANGO's NanoKnife - Analyst Blog", "After-Hours Earnings Report for July 11, 2013 : INFY, OZRK, INDB, ANGO, PPHM, CERE, SLP", "ANGO Wins Twin Approval - Analyst Blog", "Will AngioDynamics (ANGO) Beat Earnings Estimates? - Analyst Blog", "ANGO Launches BioFlo PICC Trial - Analyst Blog", "AngioDynamics Stays Neutral - Analyst Blog", "AngioDynamics Restructures Debt - Analyst Blog", "Health Canada Approves ANGO's Celerity System - Analyst Blog", "New Study for ANGO's NanoKnife - Analyst Blog", "After-Hours Earnings Report for July 11, 2013 : INFY, OZRK, INDB, ANGO, PPHM, CERE, SLP", "ANGO Gains IDE Approval for NanoKnife - Analyst Blog", "ANGO Beats on EPS, Tweaks View - Analyst Blog", "After-Hours Earnings Report for January 3, 2013 : PRGS, SHLM, SONC, ANGO, FC", "CR Bard Remains Neutral - Analyst Blog", "AngioDynamics Closes Vortex Buyout - Analyst Blog", "AngioDynamics Wins GPO Contract - Analyst Blog", "AngioDynamics to Buy Vortex - Analyst Blog", "Mixed 1Q13 for AngioDynamics - Analyst Blog", "ANGO and Microsulis Work Out Deal - Analyst Blog", "FDA Nod for Merit's Guide Wire - Analyst Blog", "FDA Clears Angio's BioFlo PICC - Analyst Blog", "Bard Remains Neutral - Analyst Blog", "Weekly CEO Buys Highlight: JPM, ROG, PBY, ANGO, MCHX", "Earnings Preview: C.R. Bard - Analyst Blog", "AngioDynamics Beats 4Q &'12 Ests - Analyst Blog", "After-Hours Earnings Report for July 12, 2012 : OZRK, RECN, ANGO", "After-Hours Earnings Report for October 8, 2012 : ANGO", "Angio's NanoKnife Makes Headway - Analyst Blog", "CR Bard Boosts Shareholder Returns - Analyst Blog", "AngioDynamics Remains Neutral - Analyst Blog", "Bard Remains Neutral - Analyst Blog", "The Zacks Analyst Blog Highlights: AngioDynamics, J.P. Morgan, Bank of America, KeyCorp and CR Bard - Press Releases", "Angio Completes Key Acquisition - Analyst Blog", "CR Bard Beats EPS Est., Lags Rev - Analyst Blog", "BSD Medical Misses in 3Q - Analyst Blog", "ANGO Mixed, Adjusts View - Analyst Blog", "S&P 500 Tests Support at its 14-Day Moving Average", "AngioDynamics' NeverTouch Kit OK'd - Analyst Blog", "Earnings Scorecard: C.R. Bard - Analyst Blog", "AngioDynamics to Buy Navilyst - Analyst Blog", "Bard Tops in 4Q, Charges Crimp Net - Analyst Blog", "Earnings Preview: C.R. Bard - Analyst Blog", "AngioDynamics Ships NanoKnife Again - Analyst Blog", "ANGO Mixed, Adjusts View - Analyst Blog", "Bearish MACD for AngioDynamics - Tale of the Tape", "Success for BSD's Rental Program - Analyst Blog", "Retaining AngioDynamics at Neutral - Analyst Blog", "AngioDynamics Beats, Tweaks View - Analyst Blog", "Milestone for BSD's MicroThermX - Analyst Blog", "BSD, AngioCare in MicroThermX Pact - Analyst Blog", "AngioDynamics Cuts View on Recall - Analyst Blog", "BSD Medical's MicroThermX at RSNA - Analyst Blog", "C.R. Bard Reaffirmed Neutral - Analyst Blog", "BSD, Synapse in MicroThermX Tie-up - Analyst Blog", "Opening View: DJIA Heads Higher on Euro-Zone Optimism; Wall Street Mourns Apple Titan Steve Jobs", "Opening View: Bulls Bolstered by Bernanke, Banking", "AngioDynamics Concludes Enrollment - Analyst Blog"], "Elapsed Time": ["JUN 15, 2020", "JUN 3, 2020", "MAY 17, 2020", "MAY 17, 2020", "MAY 15, 2020", "APR 29, 2020", "APR 19, 2020", "APR 19, 2020", "JUN 15, 2020", "APR 8, 2020", "MAR 24, 2020", "MAR 15, 2020", "MAR 15, 2020", "MAR 13, 2020", "FEB 16, 2020", "JAN 19, 2020", "APR 14, 2020", "JAN 7, 2020", "DEC 15, 2019", "OCT 15, 2019", "OCT 3, 2019", "OCT 3, 2019", "SEP 30, 2019", "AUG 23, 2019", "JAN 7, 2020", "APR 2, 2019", "APR 2, 2019", "APR 2, 2019", "APR 2, 2019", "APR 1, 2019", "MAR 26, 2019", "MAR 12, 2019", "JUL 10, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 5, 2019", "MAR 5, 2019", "MAR 5, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 8, 2019", "MAR 1, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 27, 2019", "FEB 27, 2019", "MAR 4, 2019", "FEB 27, 2019", "FEB 27, 2019", "FEB 26, 2019", "FEB 26, 2019", "FEB 25, 2019", "FEB 25, 2019", "FEB 22, 2019", "FEB 27, 2019", "FEB 22, 2019", "FEB 21, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 19, 2019", "FEB 19, 2019", "FEB 18, 2019", "FEB 22, 2019", "FEB 22, 2019", "FEB 14, 2019", "FEB 13, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 11, 2019", "FEB 15, 2019", "FEB 8, 2019", "FEB 7, 2019", "FEB 7, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 8, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 4, 2019", "FEB 3, 2019", "FEB 1, 2019", "FEB 1, 2019", "FEB 1, 2019", "FEB 6, 2019", "FEB 1, 2019", "FEB 1, 2019", "FEB 1, 2019", "JAN 31, 2019", "JAN 31, 2019", "JAN 31, 2019", "JAN 31, 2019", "FEB 1, 2019", "JAN 30, 2019", "JAN 30, 2019", "JAN 30, 2019", "JAN 28, 2019", "JAN 25, 2019", "JAN 23, 2019", "JAN 23, 2019", "JAN 30, 2019", "JAN 30, 2019", "JAN 30, 2019", "JAN 4, 2019", "JAN 3, 2019", "DEC 28, 2018", "DEC 7, 2018", "OCT 27, 2018", "JAN 18, 2019", "JAN 7, 2019", "SEP 27, 2018", "SEP 20, 2018", "SEP 20, 2018", "SEP 19, 2018", "SEP 14, 2018", "SEP 7, 2018", "OCT 1, 2018", "AUG 16, 2018", "AUG 10, 2018", "JUL 30, 2018", "JUL 30, 2018", "JUL 17, 2018", "JUL 12, 2018", "JUL 11, 2018", "AUG 21, 2018", "JUL 10, 2018", "JUL 6, 2018", "JUL 2, 2018", "APR 30, 2018", "APR 3, 2018", "APR 2, 2018", "APR 1, 2018", "JUL 11, 2018", "JUL 10, 2018", "JUL 6, 2018", "JAN 24, 2018", "JAN 10, 2018", "JAN 9, 2018", "JAN 5, 2018", "MAR 29, 2018", "JAN 4, 2018", "JAN 3, 2018", "JAN 3, 2018", "OCT 30, 2017", "OCT 4, 2017", "OCT 2, 2017", "SEP 28, 2017", "JAN 4, 2018", "SEP 26, 2017", "SEP 18, 2017", "AUG 18, 2017", "AUG 4, 2017", "JUL 24, 2017", "JUL 19, 2017", "JUL 18, 2017", "SEP 27, 2017", "MAY 1, 2017", "APR 10, 2017", "APR 4, 2017", "MAR 31, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 15, 2017", "MAY 3, 2017", "NOV 28, 2016", "NOV 25, 2016", "NOV 16, 2016", "NOV 10, 2016", "NOV 9, 2016", "NOV 4, 2016", "JAN 9, 2017", "NOV 3, 2016", "NOV 3, 2016", "NOV 2, 2016", "NOV 2, 2016", "NOV 2, 2016", "NOV 1, 2016", "NOV 1, 2016", "NOV 3, 2016", "OCT 31, 2016", "OCT 31, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 27, 2016", "OCT 27, 2016", "OCT 27, 2016", "NOV 1, 2016", "OCT 26, 2016", "OCT 25, 2016", "OCT 25, 2016", "OCT 24, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 25, 2016", "OCT 25, 2016", "OCT 24, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 26, 2016", "SEP 22, 2016", "SEP 21, 2016", "SEP 20, 2016", "SEP 8, 2016", "JUL 14, 2016", "JUL 12, 2016", "JUL 8, 2016", "OCT 4, 2016", "APR 8, 2016", "APR 7, 2016", "APR 7, 2016", "APR 7, 2016", "APR 6, 2016", "APR 4, 2016", "MAR 11, 2016", "APR 8, 2016", "FEB 9, 2016", "JAN 8, 2016", "JAN 7, 2016", "JAN 7, 2016", "DEC 7, 2015", "NOV 18, 2015", "OCT 20, 2015", "MAR 10, 2016", "OCT 9, 2015", "OCT 8, 2015", "OCT 5, 2015", "JUL 17, 2015", "JUL 13, 2015", "APR 13, 2015", "APR 10, 2015", "OCT 12, 2015", "APR 9, 2015", "APR 7, 2015", "JAN 30, 2015", "JAN 9, 2015", "JAN 8, 2015", "JAN 8, 2015", "JAN 8, 2015", "APR 9, 2015", "APR 9, 2015", "APR 7, 2015", "JAN 30, 2015", "JAN 6, 2015", "JAN 6, 2015", "DEC 19, 2014", "DEC 18, 2014", "JAN 8, 2015", "DEC 15, 2014", "DEC 11, 2014", "DEC 5, 2014", "DEC 3, 2014", "DEC 3, 2014", "DEC 2, 2014", "DEC 1, 2014", "DEC 17, 2014", "NOV 28, 2014", "NOV 28, 2014", "NOV 26, 2014", "NOV 26, 2014", "NOV 25, 2014", "NOV 25, 2014", "NOV 24, 2014", "DEC 1, 2014", "NOV 21, 2014", "NOV 20, 2014", "NOV 18, 2014", "NOV 18, 2014", "NOV 17, 2014", "NOV 14, 2014", "NOV 12, 2014", "NOV 21, 2014", "NOV 11, 2014", "NOV 10, 2014", "NOV 10, 2014", "NOV 7, 2014", "NOV 7, 2014", "NOV 7, 2014", "NOV 6, 2014", "NOV 12, 2014", "NOV 5, 2014", "NOV 4, 2014", "NOV 4, 2014", "NOV 4, 2014", "NOV 4, 2014", "NOV 3, 2014", "OCT 31, 2014", "NOV 5, 2014", "NOV 5, 2014", "OCT 27, 2014", "OCT 24, 2014", "OCT 24, 2014", "OCT 24, 2014", "OCT 22, 2014", "OCT 20, 2014", "OCT 29, 2014", "OCT 17, 2014", "OCT 16, 2014", "OCT 14, 2014", "OCT 14, 2014", "OCT 13, 2014", "OCT 10, 2014", "OCT 9, 2014", "OCT 17, 2014", "MAY 23, 2014", "APR 14, 2014", "APR 10, 2014", "APR 10, 2014", "APR 9, 2014", "APR 9, 2014", "JUL 24, 2014", "MAR 13, 2014", "MAR 10, 2014", "MAR 10, 2014", "MAR 6, 2014", "MAR 3, 2014", "FEB 28, 2014", "MAR 17, 2014", "FEB 25, 2014", "FEB 25, 2014", "FEB 21, 2014", "FEB 21, 2014", "FEB 19, 2014", "FEB 14, 2014", "FEB 11, 2014", "FEB 27, 2014", "FEB 25, 2014", "FEB 5, 2014", "FEB 3, 2014", "FEB 3, 2014", "JAN 31, 2014", "JAN 31, 2014", "FEB 10, 2014", "FEB 10, 2014", "FEB 5, 2014", "JAN 21, 2014", "JAN 16, 2014", "JAN 15, 2014", "JAN 15, 2014", "JAN 15, 2014", "JAN 24, 2014", "JAN 24, 2014", "JAN 14, 2014", "JAN 13, 2014", "JAN 10, 2014", "JAN 10, 2014", "JAN 10, 2014", "JAN 9, 2014", "JAN 15, 2014", "JAN 14, 2014", "JAN 14, 2014", "JAN 13, 2014", "DEC 3, 2013", "DEC 2, 2013", "NOV 27, 2013", "NOV 27, 2013", "JAN 7, 2014", "NOV 27, 2013", "NOV 25, 2013", "NOV 25, 2013", "NOV 25, 2013", "NOV 21, 2013", "NOV 20, 2013", "NOV 19, 2013", "NOV 27, 2013", "NOV 27, 2013", "OCT 24, 2013", "OCT 18, 2013", "OCT 16, 2013", "OCT 15, 2013", "OCT 10, 2013", "NOV 14, 2013", "OCT 7, 2013", "OCT 3, 2013", "SEP 26, 2013", "SEP 19, 2013", "AUG 23, 2013", "JUL 11, 2013", "JUN 28, 2013", "OCT 9, 2013", "OCT 7, 2013", "OCT 3, 2013", "SEP 26, 2013", "SEP 19, 2013", "AUG 23, 2013", "JUL 11, 2013", "JUN 25, 2013", "JAN 4, 2013", "JAN 3, 2013", "DEC 6, 2012", "OCT 17, 2012", "OCT 11, 2012", "OCT 10, 2012", "OCT 9, 2012", "JAN 24, 2013", "SEP 28, 2012", "SEP 4, 2012", "AUG 23, 2012", "JUL 21, 2012", "JUL 16, 2012", "JUL 13, 2012", "JUL 12, 2012", "OCT 8, 2012", "JUL 6, 2012", "JUN 14, 2012", "JUN 4, 2012", "MAY 30, 2012", "MAY 24, 2012", "MAY 23, 2012", "APR 25, 2012", "JUL 10, 2012", "APR 5, 2012", "APR 4, 2012", "FEB 15, 2012", "FEB 13, 2012", "FEB 2, 2012", "FEB 1, 2012", "JAN 30, 2012", "APR 24, 2012", "JAN 19, 2012", "JAN 12, 2012", "JAN 11, 2012", "JAN 10, 2012", "JAN 6, 2012", "JAN 6, 2012", "DEC 28, 2011", "JAN 27, 2012", "DEC 20, 2011", "DEC 12, 2011", "DEC 7, 2011", "OCT 6, 2011", "JUL 14, 2011", "DEC 27, 2011"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/why-you-need-this-medical-device-company-on-your-radar-2020-06-15", "https://www.nasdaq.com/articles/validea-kenneth-fisher-strategy-daily-upgrade-report-6-3-2020-2020-06-03", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-kenneth-fisher-5-17-2020-2020-05-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joseph-piotroski-5-17-2020-2020-05-17", "https://www.nasdaq.com/articles/validea-kenneth-fisher-strategy-daily-upgrade-report-5-15-2020-2020-05-15", "https://www.nasdaq.com/articles/validea-kenneth-fisher-strategy-daily-upgrade-report-4-29-2020-2020-04-29", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-kenneth-fisher-4-19-2020-2020-04-19", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joseph-piotroski-4-19-2020-2020-04-19", "https://www.nasdaq.com/articles/why-you-need-this-medical-device-company-on-your-radar-2020-06-15", "https://www.nasdaq.com/articles/angiodynamics-ango-q3-2020-earnings-call-transcript-2020-04-08", "https://www.nasdaq.com/articles/notable-tuesday-option-activity%3A-goog-ango-fb-2020-03-24", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-kenneth-fisher-3-15-2020-2020-03-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joseph-piotroski-3-15-2020-2020-03-15", "https://www.nasdaq.com/articles/validea-kenneth-fisher-strategy-daily-upgrade-report-3-13-2020-2020-03-13", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joseph-piotroski-2-16-2020-2020-02-16", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joseph-piotroski-1-19-2020-2020-01-19", "https://www.nasdaq.com/articles/validea-kenneth-fisher-strategy-daily-upgrade-report-4-14-2020-2020-04-14", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-07-2020%3A-apls-xers-ango-jnj-pfe-abt-mrk-amgn-2020-01-07", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joseph-piotroski-12-15-2019-2019-12-15", "https://www.nasdaq.com/articles/angiodynamics-ango-q1-2020-earnings-call-transcript-2019-10-15", "https://www.nasdaq.com/articles/why-gopro-angiodynamics-and-resources-connection-slumped-today-2019-10-03", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-03-2019%3A-apdn-pbyi-ango-jnj-pfe-abt-mrk-amgn-2019-10-03", "https://www.nasdaq.com/articles/mondays-etf-movers%3A-ihi-gdxj-2019-09-30", "https://www.nasdaq.com/articles/relative-strength-alert-for-angiodynamics-2019-08-23", "https://www.nasdaq.com/articles/angiodynamics-ango-q2-2020-earnings-call-transcript-2020-01-07", "https://www.nasdaq.com/articles/angiodynamics-ango-q3-2019-earnings-conference-call-transcript-2019-04-03", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-02-2019%3A-adma-evok-ango-jnj-pfe-abt-mrk-amgn-2019-04-02", "https://www.nasdaq.com/articles/angiodynamics-ango-q3-2019-earnings-conference-call-transcript-2019-04-02", "https://www.nasdaq.com/articles/earnings-reaction-history%3A-angiodynamics-57.1-follow-through-indicator-7.3-sensitive-2019", "https://www.nasdaq.com/articles/pre-market-earnings-report-april-2-2019-wba-lw-ango-mtnb-2019-04-01", "https://www.nasdaq.com/articles/analysts-estimate-angiodynamics-ango-to-report-a-decline-in-earnings%3A-what-to-look-out-for", "https://www.nasdaq.com/articles/avanos-avns-q4-earnings-beat-revenues-miss-shares-down-2019-03-12", "https://www.nasdaq.com/articles/angiodynamics-ango-q4-2019-earnings-call-transcript-2019-07-11", "https://www.nasdaq.com/articles/cooper-companies-coo-q1-earnings-beat-revenues-rise-y-y-2019-03-06", "https://www.nasdaq.com/articles/gnc-holdings-gnc-q4-earnings-miss-estimates-margins-fall-2019-03-06", "https://www.nasdaq.com/articles/heres-why-you-should-invest-in-angiodynamics-stock-now-2019-03-05", "https://www.nasdaq.com/articles/hms-holdings-hmsy-q4-earnings-beat-revenues-rise-y-y-2019-03-05", "https://www.nasdaq.com/articles/pra-healths-prah-q4-earnings-top-revenues-lag-estimates-2019-03-05", "https://www.nasdaq.com/articles/inogen-ingn-q4-earnings-beat-estimates-rental-revenues-up-2019-03-04", "https://www.nasdaq.com/articles/opko-health-opk-reports-loss-in-q4-misses-on-revenues-2019-03-04", "https://www.nasdaq.com/articles/amn-healthcare-amn-q4-earnings-top-revenues-lag-estimates-2019-03-08", "https://www.nasdaq.com/articles/bio-rad-bio-earnings-and-revenues-beat-estimates-in-q4-2019-03-01", "https://www.nasdaq.com/articles/new-strong-buy-stocks-february-28th-2019-02-28", "https://www.nasdaq.com/articles/amedisys-amed-tops-earnings-and-revenue-estimates-in-q4-2019-02-28", "https://www.nasdaq.com/articles/orthofix-ofix-earnings-beat-estimates-in-q4-margins-fall-2019-02-28", "https://www.nasdaq.com/articles/patterson-companies-pdco-earnings-match-estimates-in-q3-2019-02-28", "https://www.nasdaq.com/articles/commit-buy-angiodynamics-20-earn-9-annualized-using-options-2019-02-27", "https://www.nasdaq.com/articles/tandem-tndm-posts-earnings-in-q4-revenues-top-estimates-2019-02-27", "https://www.nasdaq.com/articles/penumbra-pen-earnings-and-revenues-beat-estimates-in-q4-2019-03-04", "https://www.nasdaq.com/articles/fresenius-medical-fms-earnings-beat-revenues-miss-in-q4-2019-02-27", "https://www.nasdaq.com/articles/masimo-masi-q4-earnings-and-revenues-beat-guidance-solid-2019-02-27", "https://www.nasdaq.com/articles/teleflex-tfx-q4-earnings-miss-estimates-margins-rise-2019-02-26", "https://www.nasdaq.com/articles/integras-iart-q4-earnings-and-revenues-beat-estimates-2019-02-26", "https://www.nasdaq.com/articles/dexcoms-dxcm-q4-earnings-beat-international-revenues-up-2019-02-25", "https://www.nasdaq.com/articles/chemed-che-q4-earnings-beat-estimates-gross-margin-falls-2019-02-25", "https://www.nasdaq.com/articles/allscripts-mdrx-q4-earnings-lag-estimates-bookings-up-y-y-2019-02-22", "https://www.nasdaq.com/articles/insulet-podd-beats-earnings-and-revenue-estimates-in-q4-2019-02-27", "https://www.nasdaq.com/articles/nuvasive-nuva-q4-earnings-beat-estimates-margins-fall-2019-02-22", "https://www.nasdaq.com/articles/genomic-health-ghdx-q4-earnings-beat-estimates-margins-up-2019-02-21", "https://www.nasdaq.com/articles/cvs-healths-cvs-q4-earnings-top-estimates-margins-up-2019-02-20", "https://www.nasdaq.com/articles/henry-scheins-hsic-q4-earnings-top-revenues-lag-estimates-2019-02-20", "https://www.nasdaq.com/articles/medtronic-mdt-beats-on-q3-earnings-gross-margin-down-2019-02-19", "https://www.nasdaq.com/articles/ecolab-ecl-earnings-and-revenues-match-estimates-in-q4-2019-02-19", "https://www.nasdaq.com/articles/cryolife-cry-earnings-miss-revenues-top-estimates-in-q4-2019-02-18", "https://www.nasdaq.com/articles/integer-holdings-itgr-q4-earnings-beat-19-view-strong-2019-02-22", "https://www.nasdaq.com/articles/nuvasive-nuva-q4-earnings-beat-estimates-margins-fall-2019-02-22", "https://www.nasdaq.com/articles/quest-diagnostics-dgx-q4-earnings-in-line-margins-down-2019-02-14", "https://www.nasdaq.com/articles/medidata-mdso-q4-earnings-beat-revenues-miss-estimates-2019-02-13", "https://www.nasdaq.com/articles/bruker-brkr-q4-earnings-in-line-margin-growth-strong-2019-02-12", "https://www.nasdaq.com/articles/steris-ste-q3-earnings-in-line-revenues-beat-estimates-2019-02-12", "https://www.nasdaq.com/articles/iradimed-irmd-q4-earnings-surpass-estimates-margins-up-2019-02-11", "https://www.nasdaq.com/articles/quidel-qdel-q4-earnings-and-revenues-surpass-estimates-2019-02-15", "https://www.nasdaq.com/articles/phirbo-pahc-q2-earnings-lag-estimates-operating-margin-up-2019-02-08", "https://www.nasdaq.com/articles/labcorps-lh-q4-earnings-and-revenues-surpass-estimates-2019-02-07", "https://www.nasdaq.com/articles/cardinal-health-cah-beats-on-q2-earnings-ups-fy19-view-2019-02-07", "https://www.nasdaq.com/articles/myriad-genetics-mygn-q2-earnings-revenues-miss-estimates-2019-02-06", "https://www.nasdaq.com/articles/cerner-cern-q4-earnings-meet-estimates-revenues-miss-2019-02-06", "https://www.nasdaq.com/articles/luminex-lmnx-q4-earnings-miss-2019-guidance-lacks-luster-2019-02-06", "https://www.nasdaq.com/articles/haemonetics-hae-earnings-top-revenues-lag-estimates-in-q3-2019-02-06", "https://www.nasdaq.com/articles/omnicell-omcl-q4-earnings-beat-estimates-revenues-miss-2019-02-08", "https://www.nasdaq.com/articles/qiagens-qgen-q4-earnings-in-line-revenues-miss-mark-2019-02-05", "https://www.nasdaq.com/articles/becton-dickinson-bdx-q1-earnings-in-line-with-estimates-2019-02-05", "https://www.nasdaq.com/articles/omnicell-solid-on-geographic-expansion-amid-stiff-competition-2019-02-04", "https://www.nasdaq.com/articles/angiodynamics-ango-up-8.7-since-last-earnings-report%3A-can-it-continue-2019-02-03", "https://www.nasdaq.com/articles/perkinelmer-pki-q4-earnings-beat-diagnostics-grows-y-y-2019-02-01", "https://www.nasdaq.com/articles/mckesson-mck-beats-on-q3-earnings-gains-from-solid-view-2019-02-01", "https://www.nasdaq.com/articles/cardiovascular-systems-csii-q2-earnings-top-revenues-meet-2019-02-01", "https://www.nasdaq.com/articles/boston-scientific-bsx-beats-on-q4-earnings-margins-dip-2019-02-06", "https://www.nasdaq.com/articles/edwards-lifesciences-ew-q4-earnings-in-line-revenues-top-2019-02-01", "https://www.nasdaq.com/articles/abiomed-abmd-q3-earnings-beat-impella-maintains-momentum-2019-02-01", "https://www.nasdaq.com/articles/idexx-idxx-q4-earnings-top-estimates-raises-19-eps-view-2019-02-01", "https://www.nasdaq.com/articles/hologics-holx-q1-earnings-beat-estimates-guidance-raised-2019-01-31", "https://www.nasdaq.com/articles/surmodics-srdx-q1-earnings-revenues-beat-guidance-solid-2019-01-31", "https://www.nasdaq.com/articles/amerisourcebergen-abc-beats-on-q1-earnings-trims-eps-view-2019-01-31", "https://www.nasdaq.com/articles/baxters-bax-earnings-revenues-beat-estimates-in-q4-2019-01-31", "https://www.nasdaq.com/articles/zimmer-biomet-zbh-q4-earnings-meet-estimates-revenues-top-2019-02-01", "https://www.nasdaq.com/articles/align-technology-algn-beats-on-earnings-and-revenues-in-q4-2019-01-30", "https://www.nasdaq.com/articles/varian-strong-on-global-expansion-and-proton-therapy-arm-2019-01-30", "https://www.nasdaq.com/articles/stryker-syk-q4-earnings-beat-international-revenues-surge-2019-01-30", "https://www.nasdaq.com/articles/hill-roms-hrc-earnings-and-revenues-top-estimates-in-q1-2019-01-28", "https://www.nasdaq.com/articles/intuitive-surgical-isrg-earnings-miss-revenues-beat-in-q4-2019-01-25", "https://www.nasdaq.com/articles/accurays-aray-q2-loss-narrows-radixact-demand-shoots-up-2019-01-23", "https://www.nasdaq.com/articles/conmed-cnmd-q4-earnings-match-estimates-revenues-beat-2019-01-23", "https://www.nasdaq.com/articles/thermo-fisher-tmo-beats-on-earnings-and-revenues-in-q4-2019-01-30", "https://www.nasdaq.com/articles/align-technology-algn-beats-on-earnings-and-revenues-in-q4-2019-01-30", "https://www.nasdaq.com/articles/varian-strong-on-global-expansion-and-proton-therapy-arm-2019-01-30", "https://www.nasdaq.com/articles/angiodynamics-ango-beats-q2-earnings-and-revenue-estimates-2019-01-04", "https://www.nasdaq.com/articles/pre-market-earnings-report-january-4-2019-lw-rpm-ango-2019-01-03", "https://www.nasdaq.com/articles/angiodynamics-ango-earnings-expected-to-grow%3A-what-to-know-ahead-of-next-weeks-release", "https://www.nasdaq.com/articles/heres-why-investors-should-hold-angiodynamics-stock-now-2018-12-07", "https://www.nasdaq.com/articles/angiodynamics-ango-down-6.9-since-last-earnings-report%3A-can-it-rebound-2018-10-27", "https://www.nasdaq.com/articles/heres-why-investors-should-hold-angiodynamics-ango-now-2019-01-18", "https://www.nasdaq.com/articles/angiodynamics-ango-q2-earnings-beat-on-gains-from-nanoknife-2019-01-07", "https://www.nasdaq.com/articles/earnings-reaction-history-angiodynamics-inc-500-follow-through-indicator-65-sensitive-2018", "https://www.nasdaq.com/articles/angiodynamics-ango-q1-earnings-preview%3A-what-to-watch-ahead-of-the-release-2018-09-20", "https://www.nasdaq.com/articles/whats-in-store-for-angiodynamics-ango-in-q1-earnings-2018-09-20", "https://www.nasdaq.com/articles/heres-why-you-should-hold-angiodynamics-ango-stock-now-2018-09-19", "https://www.nasdaq.com/articles/angiodynamics-ango-to-acquire-radiadyne-boost-oncology-2018-09-14", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-september-7th-2018-09-07", "https://www.nasdaq.com/articles/angiodynamics-ango-q1-earnings-miss-19-sales-view-up-2018-10-01", "https://www.nasdaq.com/articles/angiodynamics-ango-biosentry-buyout-to-boost-oncology-2018-08-16", "https://www.nasdaq.com/articles/why-is-angiodynamics-ango-up-5.02-since-its-last-earnings-report-2018-08-10", "https://www.nasdaq.com/articles/align-angiodynamics-and-caterpillar-highlighted-as-zacks-bull-and-bear-of-the-day-2018-07", "https://www.nasdaq.com/articles/bear-day-angiodynamics-ango-2018-07-30", "https://www.nasdaq.com/articles/angiodynamics-ango-q4-performance-dull-competition-rife-2018-07-17", "https://www.nasdaq.com/articles/angiodynamics-ango-misses-q4-earnings-revenue-estimates-2018-07-12", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-fastenal-profit-tops-views-2018-07-11", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-august-21st-2018-08-21", "https://www.nasdaq.com/articles/pre-market-earnings-report-july-11-2018-fast-msm-ango-2018-07-10", "https://www.nasdaq.com/articles/stocks-rally-ahead-tariff-day-2018-07-06", "https://www.nasdaq.com/articles/whats-in-store-for-angiodynamics-ango-in-q4-earnings-2018-07-02", "https://www.nasdaq.com/articles/why-is-angiodynamics-ango-up-13.9-since-its-last-earnings-report-2018-04-30", "https://www.nasdaq.com/articles/angiodynamics-ango-product-line-strong-debt-level-high-2018-04-03", "https://www.nasdaq.com/articles/angiodynamics-ango-beats-on-q3-earnings-reiterates-view-2018-04-02", "https://www.nasdaq.com/articles/angiodynamics-ango-q3-2018-earnings-conference-call-transcript-2018-04-01", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-fastenal-profit-tops-views-2018-07-11-0", "https://www.nasdaq.com/articles/pre-market-earnings-report-july-11-2018-fast-msm-ango-2018-07-10", "https://www.nasdaq.com/articles/stocks-rally-ahead-tariff-day-2018-07-06", "https://www.nasdaq.com/articles/angiodynamics-ango-banks-on-buyouts-debt-level-high-2018-01-24", "https://www.nasdaq.com/articles/zacks.com-featured-highlights-include%3A-angiodynamics-zumiez-gp-strategies-anglogold-and", "https://www.nasdaq.com/articles/bet-on-these-5-peg-ratio-based-garp-picks-2018-01-09", "https://www.nasdaq.com/articles/angiodynamics-ango-misses-on-earnings-revenues-in-q2-2018-01-05", "https://www.nasdaq.com/articles/earnings-reaction-history-angiodynamics-inc-600-follow-through-indicator-61-sensitive-2018", "https://www.nasdaq.com/articles/health-care-sector-update-01042018-angoapopastontx-2018-01-04", "https://www.nasdaq.com/articles/pre-market-earnings-report-january-4-2018-wba-mon-lw-rpm-ango-2018-01-03", "https://www.nasdaq.com/articles/can-angiodynamics-ango-pull-a-surprise-in-q2-earnings-2018-01-03", "https://www.nasdaq.com/articles/why-is-angiodynamics-ango-up-5.3-since-the-last-earnings-report-2017-10-30", "https://www.nasdaq.com/articles/angiodynamicis-ango-solero-mta-system-to-drive-growth-2017-10-04", "https://www.nasdaq.com/articles/angiodynamics-ango-misses-on-earnings-revenues-in-q1-2017-10-02", "https://www.nasdaq.com/articles/health-care-sector-update-09282017-angozynedxcm-2017-09-28", "https://www.nasdaq.com/articles/earnings-reaction-history-angiodynamics-inc-600-follow-through-indicator-63-sensitive-2018", "https://www.nasdaq.com/articles/can-angiodynamics-ango-spring-a-surprise-in-q1-earnings-2017-09-26", "https://www.nasdaq.com/articles/angiodynamics-bioflo-platform-strong-debt-levels-high-2017-09-18", "https://www.nasdaq.com/articles/angiodynamics-ango-up-10.8-since-earnings-report%3A-can-it-continue-2017-08-18", "https://www.nasdaq.com/articles/angiodynamics-inc-ango-files-10-k-fiscal-year-ended-may-31-2017-2017-08-04", "https://www.nasdaq.com/articles/monday-724-insider-buying-report-tts-ango-2017-07-24", "https://www.nasdaq.com/articles/angiodynamics-ango-shares-down-despite-q4-earnings-beat-2017-07-19", "https://www.nasdaq.com/articles/earnings-reaction-history-angiodynamics-inc-600-follow-through-indicator-54-sensitive-2017", "https://www.nasdaq.com/articles/pre-market-earnings-report-september-28-2017-acn-cag-mkc-mtn-cmd-rad-ango-fgp-omn-hhs-2017", "https://www.nasdaq.com/articles/angiodynamics-ango-down-11.7-since-earnings-report%3A-can-it-rebound-2017-05-01", "https://www.nasdaq.com/articles/angiodynamics-ango-prices-2.5m-secondary-share-offering-2017-04-10", "https://www.nasdaq.com/articles/5-cheap-value-stocks-to-tame-a-capricious-market-in-q2-2017-04-04", "https://www.nasdaq.com/articles/angiodynamics-ango-beats-on-q3-earnings-raises-2017-view-2017-03-31", "https://www.nasdaq.com/articles/heres-why-you-should-steer-clear-of-mednax-md-for-now-2017-03-29", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-30-2017-saic-lnn-ndrm-ango-titn-caas-afmd-snak-aldx-cdti", "https://www.nasdaq.com/articles/angiodynamics-microwave-tissue-ablation-system-now-ce-marked-2017-03-15", "https://www.nasdaq.com/articles/waiting-wednesday-2017-05-03", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-first-american-financial-angiodynamics-microsemi-thermo", "https://www.nasdaq.com/articles/5-garp-stocks-to-benefit-from-trump-induced-rebound-2016-11-25", "https://www.nasdaq.com/articles/angiodynamics-ango-announces-2.5m-secondary-offering-2016-11-16", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-thermo-fisher-scientific-arch-capital-group-ipg", "https://www.nasdaq.com/articles/5-garp-stocks-to-buy-now-2016-11-09", "https://www.nasdaq.com/articles/accuray-aray-incurs-wider-loss-in-q1-misses-on-revenue-2016-11-04", "https://www.nasdaq.com/articles/angiodynamics-ango-beats-q2-earnings-lifts-2017-view-2017-01-09", "https://www.nasdaq.com/articles/luminex-lmnx-misses-q3-earnings-estimates-16-view-up-2016-11-03", "https://www.nasdaq.com/articles/healthways-hway-misses-q3-earnings-revenue-estimates-2016-11-03", "https://www.nasdaq.com/articles/integer-itgr-beats-earnings-and-revenue-estimates-in-q3-2016-11-02", "https://www.nasdaq.com/articles/cerner-cern-misses-q3-earnings-revenue-estimates-2016-11-02", "https://www.nasdaq.com/articles/fresenius-medical-fms-q3-earnings-sales-beat-estimates-2016-11-02", "https://www.nasdaq.com/articles/accuray-aray-q1-loss-wider-than-expected-revenues-lag-2016-11-01", "https://www.nasdaq.com/articles/ecolabs-ecl-q3-earnings-beat-revenues-miss-estimates-2016-11-01", "https://www.nasdaq.com/articles/becton-dickinson-bdx-beats-on-q4-earnings-revenues-2016-11-03", "https://www.nasdaq.com/articles/conmed-cnmd-q3-earnings-meet-estimates-improve-y-y-2016-10-31", "https://www.nasdaq.com/articles/cardinal-health-cah-q1-earnings-beat-estimates-fall-y-y-2016-10-31", "https://www.nasdaq.com/articles/quality-systems-qsii-beats-earnings-and-revenues-in-q2-2016-10-28", "https://www.nasdaq.com/articles/stryker-syk-down-despite-q3-earnings-and-revenue-beat-2016-10-28", "https://www.nasdaq.com/articles/varian-medical-var-beats-on-q4-earnings-and-revenues-2016-10-27", "https://www.nasdaq.com/articles/universal-health-uhs-misses-q3-earnings-narrows-view-2016-10-27", "https://www.nasdaq.com/articles/your-personal-healthcare-investment-plan-2016-10-27", "https://www.nasdaq.com/articles/abiomed-abmd-q2-earnings-lag-estimates-revenues-beat-2016-11-01", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-angiodynamics-luxoft-holding-boston-scientific-popeyes", "https://www.nasdaq.com/articles/baxter-international-bax-q3-earnings-sales-top-view-up-2016-10-25", "https://www.nasdaq.com/articles/5-garp-stocks-well-positioned-to-provide-impressive-yields-2016-10-25", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-gatx-chemours-angiodynamics-koppers-holdings-and-standard", "https://www.nasdaq.com/articles/athenahealth-athn%3A-beats-on-q3-earnings-inks-partnership-2016-10-21", "https://www.nasdaq.com/articles/buy-these-5-stocks-their-solid-relative-price-strength-2016-10-21", "https://www.nasdaq.com/articles/top-10-stocks-under-20-2016-10-21", "https://www.nasdaq.com/articles/c.r.-bard-bcr-beats-q3-earnings-sales-fy16-view-up-2016-10-26", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-angiodynamics-luxoft-holding-boston-scientific-popeyes", "https://www.nasdaq.com/articles/baxter-international-bax-q3-earnings-sales-top-view-up-2016-10-25", "https://www.nasdaq.com/articles/5-garp-stocks-well-positioned-to-provide-impressive-yields-2016-10-25", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-gatx-chemours-angiodynamics-koppers-holdings-and-standard", "https://www.nasdaq.com/articles/athenahealth-athn%3A-beats-on-q3-earnings-inks-partnership-2016-10-21", "https://www.nasdaq.com/articles/buy-these-5-stocks-their-solid-relative-price-strength-2016-10-21", "https://www.nasdaq.com/articles/top-10-stocks-under-20-2016-10-21", "https://www.nasdaq.com/articles/baxter-sharesource-successfully-manages-home-dialysis-2016-10-20", "https://www.nasdaq.com/articles/angiodynamics-hits-new-52-week-high-on-solid-q4-results-2016-09-22", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-tenneco-wns-angiodynamics-teleflex-and-j2-global-2016-09-21", "https://www.nasdaq.com/articles/5-garp-stocks-poised-to-deliver-good-returns-2016-09-20", "https://www.nasdaq.com/articles/angiodynamics-ango-hits-52-week-high-on-positive-view-2016-09-08", "https://www.nasdaq.com/articles/angiodynamics-ango-tops-q4-earnings-17-view-positive-2016-07-14", "https://www.nasdaq.com/articles/pre-market-earnings-report-july-13-2016-cbsh-ango-2016-07-12", "https://www.nasdaq.com/articles/can-angiodynamics-ango-q4-earnings-pull-a-surprise-2016-07-08", "https://www.nasdaq.com/articles/pre-market-earnings-report-october-5-2016-mon-stz-gpn-ayi-rpm-azz-ango-2016-10-04", "https://www.nasdaq.com/articles/thermo-fisher-siemens-collaborate-to-aid-molecular-testing-2016-04-08", "https://www.nasdaq.com/articles/earnings-reaction-history-angiodynamics-inc-500-follow-through-indicator-46-sensitive-2016", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-7-2016-psmt-wdfc-recn-ango-seac-2016-04-07", "https://www.nasdaq.com/articles/natus-medical%3A-a-strong-sell-on-weak-q1-estimate-revision-2016-04-07", "https://www.nasdaq.com/articles/mazor-robotics-receives-5-orders-in-q1-shares-down-2016-04-06", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-angiodynamics-ango-2016-04-04", "https://www.nasdaq.com/articles/inogen-ingn-q4-earnings%3A-a-surprise-in-the-cards-2016-03-11", "https://www.nasdaq.com/articles/angiodynamics-tops-q3-earnings-sales-fy16-view-pruned-2016-04-08", "https://www.nasdaq.com/articles/angiodynamics%3A-health-canada-okays-celerity-with-navigation-2016-02-09", "https://www.nasdaq.com/articles/angiodynamics-q2-earnings-in-line-sales-top-16-view-cut-2016-01-08", "https://www.nasdaq.com/articles/earnings-reaction-history-angiodynamics-inc-500-follow-through-indicator-45-sensitive-2016", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-7-2016-bbby-snx-hele-psmt-wdfc-cuda-ango-tcs-fc-2016", "https://www.nasdaq.com/articles/angiodynamics%3A-fda-calls-off-warnings-against-facilities-2015-12-07", "https://www.nasdaq.com/articles/angiodynamics-addresses-fda-warning-for-nanoknife-system-2015-11-18", "https://www.nasdaq.com/articles/angiodynamics-expands-in-asia-with-nanoknife-approvals-2015-10-20", "https://www.nasdaq.com/articles/add-angiodynamics-ango-to-your-portfolio%3A-heres-why-2016-03-10", "https://www.nasdaq.com/articles/angiodynamics-down-line-q1-earnings-sales-miss-2015-10-09", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-8-2015-hele-ango-atny-aa-2015-10-08", "https://www.nasdaq.com/articles/can-angiodynamics-ango-q1-earnings-pull-a-surprise-2015-10-05", "https://www.nasdaq.com/articles/angiodynamics-q4-earnings-meet-sales-hit-by-forex-woes-analyst-blog-2015-07-17", "https://www.nasdaq.com/articles/will-angiodynamics-ango-miss-q4-earnings-estimates-analyst-blog-2015-07-13", "https://www.nasdaq.com/articles/company-news-for-april-13-2015-corporate-summary-2015-04-13", "https://www.nasdaq.com/articles/angiodynamics-lags-earnings-on-lower-sales-view-tepid-analyst-blog-2015-04-10", "https://www.nasdaq.com/articles/angiodynamics-ango-in-focus%3A-stock-falls-6.7-2015-10-12", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-9-2015-psmt-ango-rt-2015-04-09", "https://www.nasdaq.com/articles/can-angiodynamics-ango-surprise-earnings-in-q3-analyst-blog-2015-04-07", "https://www.nasdaq.com/articles/angiodynamics-celerity-system-gets-expanded-fda-approval-analyst-blog-2015-01-30", "https://www.nasdaq.com/articles/angiodynamics-beats-q2-earnings-by-a-penny-guides-up-analyst-blog-2015-01-09", "https://www.nasdaq.com/articles/earnings-reaction-history-angiodynamics-inc-500-follow-through-indicator-41-sensitive-2015", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-8-2015-bbby-psmt-cuda-hele-tcs-ango-rt-fc-eopn-voxx", "https://www.nasdaq.com/articles/natus-medical-advances-newborn-care-with-nicview-buyout-analyst-blog-2015-01-08", "https://www.nasdaq.com/articles/earnings-reaction-history-angiodynamics-inc-500-follow-through-indicator-42-sensitive-2015", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-9-2015-psmt-ango-rt-2015-04-09", "https://www.nasdaq.com/articles/can-angiodynamics-ango-surprise-earnings-in-q3-analyst-blog-2015-04-07", "https://www.nasdaq.com/articles/angiodynamics-celerity-system-gets-expanded-fda-approval-analyst-blog-2015-01-30", "https://www.nasdaq.com/articles/symmetry-surgical-neosurgical-ink-distribution-agreement-analyst-blog-2015-01-06", "https://www.nasdaq.com/articles/adverse-reimbursement-verdict-for-cyberonics-vns-therapy-analyst-blog-2015-01-06", "https://www.nasdaq.com/articles/merit-medical-hits-52-week-high-on-product-pipeline-strength-analyst-blog-2014-12-19", "https://www.nasdaq.com/articles/angiodynamics-ango-hits-52-week-high-on-positive-view-analyst-blog-2014-12-18", "https://www.nasdaq.com/articles/idexx-cag-global-growth-solid-catalyst-one-in-focus-in-15-analyst-blog-2015-01-08", "https://www.nasdaq.com/articles/merit-medical-wins-fda-approval-for-multiple-devices-analyst-blog-2014-12-15", "https://www.nasdaq.com/articles/angiodynamics-ango-signs-picc-deal-with-healthtrust-analyst-blog-2014-12-11", "https://www.nasdaq.com/articles/hologic-holx-turns-around%3A-should-you-invest-now-analyst-blog-2014-12-05", "https://www.nasdaq.com/articles/thoratec-completes-enrollment-for-heartmate-iii-ce-mark-trial-analyst-blog-2014-12-03", "https://www.nasdaq.com/articles/varian-medical-var-to-display-new-technologies-at-rsna-analyst-blog-2014-12-03", "https://www.nasdaq.com/articles/cepheid-wins-fda-clearance-for-xpert-norovirus-test-analyst-blog-2014-12-02", "https://www.nasdaq.com/articles/commit-buy-angiodynamics-15-earn-96-annualized-using-options-2014-12-01", "https://www.nasdaq.com/articles/cr-bard-strong-on-acquisitions-fda-nod-for-lutonix-dcb-analyst-blog-2014-12-17", "https://www.nasdaq.com/articles/fresenius-medical-fms-scales-52-week-high-on-strong-q3-analyst-blog-2014-11-28", "https://www.nasdaq.com/articles/edwards-lifesciences-strong-on-robust-q3-raised-outlook-analyst-blog-2014-11-28", "https://www.nasdaq.com/articles/oxford-immunotec-oxfd-looks-good%3A-stock-rises-5.6-tale-of-the-tape-2014-11-26", "https://www.nasdaq.com/articles/angiodynamics-ango-stock%3A-moving-average-crossover-alert-tale-of-the-tape-2014-11-26", "https://www.nasdaq.com/articles/sirona-dental-lags-q4-earnings-by-a-penny-tops-revenues-analyst-blog-2014-11-25", "https://www.nasdaq.com/articles/cepheid-gets-fda-clearance-for-xpert-flu-rsv-xc-test-analyst-blog-2014-11-25", "https://www.nasdaq.com/articles/cyberonics-slumps%3A-cybx-falls-5.1-in-session-tale-of-the-tape-2014-11-24", "https://www.nasdaq.com/articles/luminex-grows-on-product-launches-strategic-partnerships-analyst-blog-2014-12-01", "https://www.nasdaq.com/articles/cyberonics-cybx-in-focus%3A-stock-adds-13.4-in-session-tale-of-the-tape-2014-11-21", "https://www.nasdaq.com/articles/angiodynamics-ango-reiterates-fy15-long-term-outlook-analyst-blog-2014-11-20", "https://www.nasdaq.com/articles/navidea-biopharmaceuticals-navb-jumps%3A-stock-up-7.8-tale-of-the-tape-2014-11-18", "https://www.nasdaq.com/articles/fluidigm-fldm-now-a-strong-buy-on-key-product-releases-analyst-blog-2014-11-18", "https://www.nasdaq.com/articles/teleflex-tfx-hits-52-week-high-on-strong-q3-results-analyst-blog-2014-11-17", "https://www.nasdaq.com/articles/varian-medical-var-down-to-strong-sell-on-dismal-q3-analyst-blog-2014-11-14", "https://www.nasdaq.com/articles/abiomed-abmd-hits-52-week-high-on-strong-q2-results-analyst-blog-2014-11-12", "https://www.nasdaq.com/articles/cyberonics-beats-q2-earnings-sales-up-eps-view-retained-analyst-blog-2014-11-21", "https://www.nasdaq.com/articles/roka-bioscience-roka-in-focus%3A-stock-surges-19.3-tale-of-the-tape-2014-11-11", "https://www.nasdaq.com/articles/volcano-posts-narrower-than-expected-q3-loss-guides-low-analyst-blog-2014-11-10", "https://www.nasdaq.com/articles/strength-seen-in-dexcom-dxcm%3A-stocks-gains-14.1-tale-of-the-tape-2014-11-10", "https://www.nasdaq.com/articles/thoratec-q3-earnings-revenues-lag-estimates-down-y-y-analyst-blog-2014-11-07", "https://www.nasdaq.com/articles/foundation-medicine-slumps%3A-fmi-tumbles-9.6-in-session-tale-of-the-tape-2014-11-07", "https://www.nasdaq.com/articles/hologic-beats-q4-earnings-sales-as-all-segments-gain-analyst-blog-2014-11-07", "https://www.nasdaq.com/articles/teleflex-beats-on-q3-earnings-revenues-outlook-raised-analyst-blog-2014-11-06", "https://www.nasdaq.com/articles/thoratec-thor-down-to-strong-sell-on-growing-headwinds-analyst-blog-2014-11-12", "https://www.nasdaq.com/articles/cryolife-q3-earnings-fall-revenues-rise-y-y-shares-tank-analyst-blog-2014-11-05", "https://www.nasdaq.com/articles/becton-dickinson-bdx-beats-q4-earnings-revenues-analyst-blog-2014-11-04", "https://www.nasdaq.com/articles/mindray-medical-q3-earnings-in-line-2014-view-lowered-analyst-blog-2014-11-04", "https://www.nasdaq.com/articles/techne-corp.-tech-q1-earnings-revenues-miss-estimates-analyst-blog-2014-11-04", "https://www.nasdaq.com/articles/abiomed-tops-q2-earnings-revenues-fy15-sales-view-up-analyst-blog-2014-11-04", "https://www.nasdaq.com/articles/accuray-aray-q1-loss-wider-than-expected-revenues-lag-analyst-blog-2014-11-03", "https://www.nasdaq.com/articles/greatbatch-beats-q3-earnings-estimates-upgrades-14-view-analyst-blog-2014-10-31", "https://www.nasdaq.com/articles/symmetry-medical-q3-earnings-revenues-miss-rise-y-y-analyst-blog-2014-11-05", "https://www.nasdaq.com/articles/cryolife-q3-earnings-fall-revenues-rise-y-y-shares-tank-analyst-blog-2014-11-05", "https://www.nasdaq.com/articles/edwards-lifesciences-ew-worth-watching%3A-stock-up-11-tale-of-the-tape-2014-10-27", "https://www.nasdaq.com/articles/edwards-lifesciences-tops-q3-earnings-revenues-ups-view-analyst-blog-2014-10-24", "https://www.nasdaq.com/articles/rti-surgical-rtix-jumps%3A-stock-moves-12.6-higher-tale-of-the-tape-2014-10-24", "https://www.nasdaq.com/articles/quality-systems-misses-on-q2-fiscal-earnings-by-a-penny-analyst-blog-2014-10-24", "https://www.nasdaq.com/articles/intuitive-surgical-q3-earnings-fall-but-beat-estimates-analyst-blog-2014-10-22", "https://www.nasdaq.com/articles/after-hours-most-active-oct-20-2014-aapl-intc-qqq-bsbr-hal-ango-jpm-nct-key-abbv-foxa-mrvl", "https://www.nasdaq.com/articles/luminex-lmnx-upgraded-to-strong-buy-on-impressive-q3-analyst-blog-2014-10-29", "https://www.nasdaq.com/articles/why-angiodynamics-ango-could-be-an-impressive-growth-stock-tale-of-the-tape-2014-10-17", "https://www.nasdaq.com/articles/luminex-lmnx-crumbles%3A-stock-falls-by-7.5-tale-of-the-tape-2014-10-16", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2014-10-14", "https://www.nasdaq.com/articles/angiodynamics-ango-jumps%3A-stock-moves-5.6-higher-tale-of-the-tape-2014-10-14", "https://www.nasdaq.com/articles/company-news-for-october-13-2014-corporate-summary-2014-10-13", "https://www.nasdaq.com/articles/angiodynamics-q1-earnings-revenues-beat-15-view-up-analyst-blog-2014-10-10", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-9-2014-fdo-infy-hele-cmtl-ango-enz-voxx-joez-2014-10", "https://www.nasdaq.com/articles/cepheid-q3-loss-narrower-than-expected-sales-view-upped-analyst-blog-2014-10-17", "https://www.nasdaq.com/articles/updated-research-report-on-angiodynamics-analyst-blog-2014-05-23", "https://www.nasdaq.com/articles/weakness-seen-in-angiodynamics-ango%3A-stock-tumbles-7.8-tale-of-the-tape-2014-04-14", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-04-10-1", "https://www.nasdaq.com/articles/healthcare-stocks-resume-slide-angiodynamics-inching-lower-after-q3-earnings-miss-2014-04", "https://www.nasdaq.com/articles/earnings-reaction-history-angiodynamics-inc-500-follow-through-indicator-41-sensitive-2014", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-9-2014-bbby-apog-nog-ango-rt-sigm-atny-rell-slp-joez", "https://www.nasdaq.com/articles/angiodynamics-q4-earnings-beat-revenues-up-on-higher-sales-analyst-blog-2014-07-24", "https://www.nasdaq.com/articles/angiodynamics-ango-in-focus%3A-stock-moves-5.7-higher-tale-of-the-tape-2014-03-13", "https://www.nasdaq.com/articles/commit-buy-angiodynamics-1250-earn-86-annualized-using-options-2014-03-10", "https://www.nasdaq.com/articles/angiodynamics-gets-3rd-fda-approval-for-bioflo-analyst-blog-2014-03-10", "https://www.nasdaq.com/articles/coverage-on-covance-initiated-analyst-blog-2014-03-06", "https://www.nasdaq.com/articles/cyberonics-upped-to-buy-analyst-blog-2014-03-03", "https://www.nasdaq.com/articles/bioscrip-down-on-q4-loss-poor-outlook-analyst-blog-2014-02-28", "https://www.nasdaq.com/articles/fda-expands-angiovac-clearance-for-angiodynamics-analyst-blog-2014-03-17", "https://www.nasdaq.com/articles/wider-q4-loss-poor-outlook-at-volcano-corp.-analyst-blog-2014-02-25", "https://www.nasdaq.com/articles/balanced-view-on-omnicell-analyst-blog-2014-02-25", "https://www.nasdaq.com/articles/balanced-view-on-petmed-analyst-blog-2014-02-21", "https://www.nasdaq.com/articles/updated-research-report-on-cepheid-analyst-blog-2014-02-21", "https://www.nasdaq.com/articles/pacific-biosciences-pacb-jumps%3A-stock-moves-8.3-higher-tale-of-the-tape-2014-02-19", "https://www.nasdaq.com/articles/masimo-q4-earnings-meet-ests-analyst-blog-2014-02-14", "https://www.nasdaq.com/articles/sirona-dental-earnings-beat-by-a-penny-shares-up-analyst-blog-2014-02-11", "https://www.nasdaq.com/articles/fresenius-medical-care-beats-on-q4-earnings-analyst-blog-2014-02-27", "https://www.nasdaq.com/articles/wider-q4-loss-poor-outlook-at-volcano-corp.-analyst-blog-2014-02-25", "https://www.nasdaq.com/articles/q1-earnings-beat-revs-in-line-at-hologic-analyst-blog-2014-02-05", "https://www.nasdaq.com/articles/accuray-sees-narrower-loss-hits-52-week-high-analyst-blog-2014-02-03", "https://www.nasdaq.com/articles/accuray-aray-catches-eye%3A-stock-jumps-15.3-tale-of-the-tape-2014-02-03", "https://www.nasdaq.com/articles/cepheid-reports-q4-loss-beats-on-revs-analyst-blog-2014-01-31", "https://www.nasdaq.com/articles/abiomed-earnings-rise-tops-estimates-analyst-blog-2014-01-31", "https://www.nasdaq.com/articles/omnicell-misses-on-q4-earnings-beats-revs-analyst-blog-2014-02-10", "https://www.nasdaq.com/articles/thoratec-earnings-meet-ests-but-fall-y-y-analyst-blog-2014-02-10", "https://www.nasdaq.com/articles/luminex-earnings-beat-but-fall-y-y-shares-down-analyst-blog-2014-02-05", "https://www.nasdaq.com/articles/echo-therapeutics-applies-for-ce-mark-analyst-blog-2014-01-21", "https://www.nasdaq.com/articles/intuitive-surgical-expects-lower-revenues-analyst-blog-2014-01-16", "https://www.nasdaq.com/articles/novadaq-technologies-nvdq-in-focus%3A-stock-moves-3.1-higher-tale-of-the-tape-2014-01-15", "https://www.nasdaq.com/articles/medtronic-still-at-neutral-analyst-blog-2014-01-15", "https://www.nasdaq.com/articles/mindray-revises-revenue-guidance-analyst-blog-2014-01-15", "https://www.nasdaq.com/articles/intuitive-surgical-tops-on-q4-earnings-revs-analyst-blog-2014-01-24", "https://www.nasdaq.com/articles/volcano-sells-on-prelim-2014-outlook-analyst-blog-2014-01-14", "https://www.nasdaq.com/articles/boston-scientific-kept-at-neutral-analyst-blog-2014-01-14", "https://www.nasdaq.com/articles/angiodynamics-remains-neutral-analyst-blog-2014-01-13", "https://www.nasdaq.com/articles/angiodynamics-inc-ango-new-analyst-report-zacks-equity-research-zacks-equity-research", "https://www.nasdaq.com/articles/align-pinned-at-outperform-analyst-blog-2014-01-10", "https://www.nasdaq.com/articles/angiodynamics-misses-on-fiscal-q2-earnings-analyst-blog-2014-01-10", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-9-2014-aa-infy-psmt-snx-hele-prgs-eopn-ango-2014-01-09", "https://www.nasdaq.com/articles/illumina-rises-on-prelim-q4-results-analyst-blog-2014-01-15", "https://www.nasdaq.com/articles/volcano-sells-on-prelim-2014-outlook-analyst-blog-2014-01-14", "https://www.nasdaq.com/articles/boston-scientific-kept-at-neutral-analyst-blog-2014-01-14", "https://www.nasdaq.com/articles/angiodynamics-remains-neutral-analyst-blog-2014-01-13", "https://www.nasdaq.com/articles/dexcom-hits-new-52-week-high-analyst-blog-2013-12-03", "https://www.nasdaq.com/articles/luminex-remains-neutral-analyst-blog-2013-12-02", "https://www.nasdaq.com/articles/bsx-promus-premier-des-gets-fda-nod-analyst-blog-2013-11-27", "https://www.nasdaq.com/articles/accuray-on-growth-track-analyst-blog-2013-11-27", "https://www.nasdaq.com/articles/masimo-reaches-new-52-week-high-analyst-blog-2014-01-07", "https://www.nasdaq.com/articles/ecte-shares-surge-on-positive-study-results-analyst-blog-2013-11-27", "https://www.nasdaq.com/articles/cyberonics-beats-on-q2-earnings-guides-up-analyst-blog-2013-11-25", "https://www.nasdaq.com/articles/sirona-dental-earnings-miss-fiscal-q4-ests-analyst-blog-2013-11-25", "https://www.nasdaq.com/articles/petmed-slips-to-neutral-analyst-blog-2013-11-25", "https://www.nasdaq.com/articles/strength-seen-in-imris-imrs%3A-stock-surges-17.7-tale-of-the-tape-2013-11-21", "https://www.nasdaq.com/articles/teleflex-unveils-new-product-line-analyst-blog-2013-11-20", "https://www.nasdaq.com/articles/teleflex-unveils-new-product-line-analyst-blog-2013-11-19", "https://www.nasdaq.com/articles/tmo-life-deal-gains-regulatory-nod-analyst-blog-2013-11-27", "https://www.nasdaq.com/articles/ecte-shares-surge-on-positive-study-results-analyst-blog-2013-11-27", "https://www.nasdaq.com/articles/varian-sees-flat-earnings-lags-estimates-analyst-blog-2013-10-24", "https://www.nasdaq.com/articles/isrg-q3-earnings-beat-but-down-y-o-y-analyst-blog-2013-10-18", "https://www.nasdaq.com/articles/angiodynamics-bags-major-deal-analyst-blog-2013-10-16", "https://www.nasdaq.com/articles/ango-beats-q1-earnings-hits-52-week-high-analyst-blog-2013-10-15", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-10-2013-mu-swy-ozrk-lrn-eopn-ango-2013-10-10", "https://www.nasdaq.com/articles/syneron-medical-elos-in-focus%3A-stock-surges-16.4-tale-of-the-tape-2013-11-14", "https://www.nasdaq.com/articles/ango-launches-bioflo-picc-trial-analyst-blog-2013-10-07", "https://www.nasdaq.com/articles/angiodynamics-stays-neutral-analyst-blog-2013-10-03", "https://www.nasdaq.com/articles/angiodynamics-restructures-debt-analyst-blog-2013-09-26", "https://www.nasdaq.com/articles/health-canada-approves-angos-celerity-system-analyst-blog-2013-09-19", "https://www.nasdaq.com/articles/new-study-for-angos-nanoknife-analyst-blog-2013-08-23", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-11-2013-infy-ozrk-indb-ango-pphm-cere-slp-2013-07-11", "https://www.nasdaq.com/articles/ango-wins-twin-approval-analyst-blog-2013-06-28", "https://www.nasdaq.com/articles/will-angiodynamics-ango-beat-earnings-estimates-analyst-blog-2013-10-09", "https://www.nasdaq.com/articles/ango-launches-bioflo-picc-trial-analyst-blog-2013-10-07", "https://www.nasdaq.com/articles/angiodynamics-stays-neutral-analyst-blog-2013-10-03", "https://www.nasdaq.com/articles/angiodynamics-restructures-debt-analyst-blog-2013-09-26", "https://www.nasdaq.com/articles/health-canada-approves-angos-celerity-system-analyst-blog-2013-09-19", "https://www.nasdaq.com/articles/new-study-for-angos-nanoknife-analyst-blog-2013-08-23", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-11-2013-infy-ozrk-indb-ango-pphm-cere-slp-2013-07-11", "https://www.nasdaq.com/articles/ango-gains-ide-approval-for-nanoknife-analyst-blog-2013-06-25", "https://www.nasdaq.com/articles/ango-beats-on-eps-tweaks-view-analyst-blog-2013-01-04", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-3-2013-prgs-shlm-sonc-ango-fc-2013-01-03", "https://www.nasdaq.com/articles/cr-bard-remains-neutral-analyst-blog-2012-12-06", "https://www.nasdaq.com/articles/angiodynamics-closes-vortex-buyout-analyst-blog-2012-10-17", "https://www.nasdaq.com/articles/angiodynamics-wins-gpo-contract-analyst-blog-2012-10-11", "https://www.nasdaq.com/articles/angiodynamics-to-buy-vortex-analyst-blog-2012-10-10", "https://www.nasdaq.com/articles/mixed-1q13-for-angiodynamics-analyst-blog-2012-10-09", "https://www.nasdaq.com/articles/ango-and-microsulis-work-out-deal-analyst-blog-2013-01-24", "https://www.nasdaq.com/articles/fda-nod-for-merits-guide-wire-analyst-blog-2012-09-28", "https://www.nasdaq.com/articles/fda-clears-angios-bioflo-picc-analyst-blog-2012-09-04", "https://www.nasdaq.com/articles/bard-remains-neutral-analyst-blog-2012-08-23", "https://www.nasdaq.com/articles/weekly-ceo-buys-highlight-jpm-rog-pby-ango-mchx-2012-07-21", "https://www.nasdaq.com/articles/earnings-preview%3A-c.r.-bard-analyst-blog-2012-07-16", "https://www.nasdaq.com/articles/angiodynamics-beats-4q-12-ests-analyst-blog-2012-07-13", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-12-2012-ozrk-recn-ango-2012-07-12", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-8-2012-ango-2012-10-08", "https://www.nasdaq.com/articles/angios-nanoknife-makes-headway-analyst-blog-2012-07-06", "https://www.nasdaq.com/articles/cr-bard-boosts-shareholder-returns-analyst-blog-2012-06-14", "https://www.nasdaq.com/articles/angiodynamics-remains-neutral-analyst-blog-2012-06-04", "https://www.nasdaq.com/articles/bard-remains-neutral-analyst-blog-2012-05-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-angiodynamics-j.p.-morgan-bank-of-america-keycorp-and", "https://www.nasdaq.com/articles/angio-completes-key-acquisition-analyst-blog-2012-05-23", "https://www.nasdaq.com/articles/cr-bard-beats-eps-est.-lags-rev-analyst-blog-2012-04-25", "https://www.nasdaq.com/articles/bsd-medical-misses-in-3q-analyst-blog-2012-07-10", "https://www.nasdaq.com/articles/ango-mixed-adjusts-view-analyst-blog-2012-04-05", "https://www.nasdaq.com/articles/sp-500-tests-support-its-14-day-moving-average-2012-04-04", "https://www.nasdaq.com/articles/angiodynamics-nevertouch-kit-okd-analyst-blog-2012-02-15", "https://www.nasdaq.com/articles/earnings-scorecard%3A-c.r.-bard-analyst-blog-2012-02-13", "https://www.nasdaq.com/articles/angiodynamics-to-buy-navilyst-analyst-blog-2012-02-02", "https://www.nasdaq.com/articles/bard-tops-in-4q-charges-crimp-net-analyst-blog-2012-02-01", "https://www.nasdaq.com/articles/earnings-preview%3A-c.r.-bard-analyst-blog-2012-01-30", "https://www.nasdaq.com/articles/angiodynamics-ships-nanoknife-again-analyst-blog-2012-04-24", "https://www.nasdaq.com/articles/tuebingen-ums-deploys-bsds-system-analyst-blog-2012-01-19", "https://www.nasdaq.com/articles/bearish-macd-for-angiodynamics-tale-of-the-tape-2012-01-12", "https://www.nasdaq.com/articles/success-for-bsds-rental-program-analyst-blog-2012-01-11", "https://www.nasdaq.com/articles/retaining-angiodynamics-at-neutral-analyst-blog-2012-01-10", "https://www.nasdaq.com/articles/angiodynamics-beats-tweaks-view-analyst-blog-2012-01-06", "https://www.nasdaq.com/articles/milestone-for-bsds-microthermx-analyst-blog-2012-01-06", "https://www.nasdaq.com/articles/bsd-angiocare-in-microthermx-pact-analyst-blog-2011-12-28", "https://www.nasdaq.com/articles/angiodynamics-cuts-view-on-recall-analyst-blog-2012-01-27", "https://www.nasdaq.com/articles/bsd-medicals-microthermx-at-rsna-analyst-blog-2011-12-20", "https://www.nasdaq.com/articles/c.r.-bard-reaffirmed-neutral-analyst-blog-2011-12-12", "https://www.nasdaq.com/articles/bsd-synapse-in-microthermx-tie-up-analyst-blog-2011-12-07", "https://www.nasdaq.com/articles/opening-view-djia-heads-higher-euro-zone-optimism-wall-street-mourns-apple-titan-steve", "https://www.nasdaq.com/articles/opening-view-bulls-bolstered-bernanke-banking-2011-07-14", "https://www.nasdaq.com/articles/angiodynamics-concludes-enrollment-analyst-blog-2011-12-27"], "Content": []}